Varian gets China OK for Halcyon system

By staff writers

November 28, 2018 -- Radiation oncology firm Varian Medical Systems has received clearance for its Halcyon system by the China National Medical Product Administration.

The clearance allows the firm to market its cancer treatment system in China.

Halcyon has already received U.S. Food and Drug Administration 510(k) clearance in the U.S. and the CE Mark in Europe, as well as approval in Japan, Brazil, India, and Taiwan since the system's launch in May 2017, according to Varian.

Copyright © 2018

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking